MBL2 and tuberculosis: The pooled ORs revealed that MBL2 A > B gene polymorphism is not associated with TB risk in allelic contrast (B vs. A: p = 0.095; OR = 0.901, 95% CI = 0.797 to 1.018), homozygous (BB vs. AA: p = 0.868; OR = 0.820, 95% CI = 0.532 to 1.264), heterozygous (AB vs. AA: p = 0.203; OR = 0.872, 95% CI = 0.706 to 1.077), dominant (BB + AB vs. AA: p = 0.484; OR = 1.166, 95% CI = 0.759 to 1.789), and recessive (BB vs. AA + AB: p = 0.249; OR = 0.878, 95% CI = 0.703 to 1.095) genetic models (Fig. 2).